Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer

Objective: Triple negative breast cancer (TNBC) is known to have aggressive clinical course and a high risk of recurrence. Given the lack of effective targeted therapy options, paclitaxel-based chemotherapy is still the primary option for TNBC patients. However, patients who fail to achieve a comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shanshan, Wu, Hao, Wu, Xiaohong, You, Zilong, Jiang, Yang, Liang, Xiaoshuan, Chen, Zhuo, Zhang, Ye, Wei, Wei, Jiang, Yongdong, Chen, Yanbo, Song, Yanni, Pang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969978/
https://www.ncbi.nlm.nih.gov/pubmed/33747900
http://dx.doi.org/10.3389/fonc.2021.535230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969978/
https://www.ncbi.nlm.nih.gov/pubmed/33747900
http://dx.doi.org/10.3389/fonc.2021.535230

Ejemplares similares